产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
---|---|---|---|---|---|---|---|
GC31951-5mg |
|
477202-00-9 |
Ipilimumab (MDX-010) - Glpbio |
0 | 需询价 | C6742H9972N1732O2004S40 | |
GC31950-25mg |
|
64924-67-0 |
Halofuginone hydrobromide (RU-19110 (hydrobromide)) - Glpbio |
0 | 需询价 | C16H18Br2ClN3O3 | |
GC31950-10mg |
|
64924-67-0 |
Halofuginone hydrobromide (RU-19110 (hydrobromide)) - Glpbio |
0 | 需询价 | C16H18Br2ClN3O3 | |
GC31950-5mg |
|
64924-67-0 |
Halofuginone hydrobromide (RU-19110 (hydrobromide)) - Glpbio |
0 | 需询价 | C16H18Br2ClN3O3 | |
GC31950-10mM(1mLinDMSO) |
|
64924-67-0 |
Halofuginone hydrobromide (RU-19110 (hydrobromide)) - Glpbio |
0 | 需询价 | C16H18Br2ClN3O3 | |
GC31949-100mg |
|
2098884-53-6 |
PAT-1251 Hydrochloride - Glpbio |
0 | 需询价 | C18H18ClF4N3O3 | |
GC31949-50mg |
|
2098884-53-6 |
PAT-1251 Hydrochloride - Glpbio |
0 | 需询价 | C18H18ClF4N3O3 | |
GC31949-25mg |
|
2098884-53-6 |
PAT-1251 Hydrochloride - Glpbio |
0 | 需询价 | C18H18ClF4N3O3 | |
GC31949-10mg |
|
2098884-53-6 |
PAT-1251 Hydrochloride - Glpbio |
0 | 需询价 | C18H18ClF4N3O3 | |
GC31949-5mg |
|
2098884-53-6 |
PAT-1251 Hydrochloride - Glpbio |
0 | 需询价 | C18H18ClF4N3O3 | |
GC31947-10mg |
|
129424-08-4 |
ICI 211965 (ZM-211965) - Glpbio |
0 | 需询价 | C24H23NO2S | |
GC31947-5mg |
|
129424-08-4 |
ICI 211965 (ZM-211965) - Glpbio |
0 | 需询价 | C24H23NO2S | |
GC31947-1mg |
|
129424-08-4 |
ICI 211965 (ZM-211965) - Glpbio |
0 | 需询价 | C24H23NO2S | |
GC31946-200mg |
|
3166-62-9 |
Methylbenactyzium Bromide - Glpbio |
0 | 需询价 | C21H28BrNO3 | |
GC31946-100mg |
|
3166-62-9 |
Methylbenactyzium Bromide - Glpbio |
0 | 需询价 | C21H28BrNO3 | |
GC31946-50mg |
|
3166-62-9 |
Methylbenactyzium Bromide - Glpbio |
0 | 需询价 | C21H28BrNO3 | |
GC31946-10mM(1mLinDMSO) |
|
3166-62-9 |
Methylbenactyzium Bromide - Glpbio |
0 | 需询价 | C21H28BrNO3 | |
GC31945-5mg |
|
— |
Hosenkoside B - Glpbio |
0 | 需询价 | — | |
GC31945-10mM(1mLinDMSO) |
|
— |
Hosenkoside B - Glpbio |
0 | 需询价 | — | |
GC31944-20mg |
|
136564-67-5 |
LTD4 antagonist 1 - Glpbio |
0 | 需询价 | C31H32F3N3O5S | |